Advanced Heart Failure
Medicines, monitoring and device options for heart failure that is getting harder to manage.
In cardiac amyloidosis, misfolded proteins called amyloid build up in the heart muscle and make it thick and stiff. The heart then has trouble filling with blood, which leads to heart failure symptoms.
The two main types are transthyretin amyloidosis, called ATTR, and light chain amyloidosis, called AL. Cardiac amyloidosis is often missed for years. Newer treatments can slow the disease, so an early diagnosis matters.
Specific patterns on the heart ultrasound can raise suspicion for amyloidosis.
Blood and urine tests check for AL amyloidosis. A nuclear heart scan can help identify ATTR.
When needed, a biopsy and genetic testing confirm the type, which decides treatment.
Medicines can slow ATTR amyloidosis. AL amyloidosis is treated together with a hematologist.
Fluid, blood pressure and rhythm are managed carefully, since the stiff heart responds differently to some medicines.
Bring your echocardiogram reports, any nerve or carpal tunnel history and a list of your medicines.
New patient informationIt is more common than once thought, especially ATTR amyloidosis in older adults. It is often found late because the symptoms look like other heart conditions.
One form of ATTR amyloidosis is inherited. Genetic testing can tell whether family members should be checked.
Yes. Several medicines can slow ATTR amyloidosis, and AL amyloidosis is treated with therapy directed at the abnormal cells.